Thermoreversibly Assembled Polymersomes for Highly Efficient Loading, Processing, and Delivery of Protein and siRNA Biologics
Although great advances in siRNA and mRNA delivery have been made (eg with lipid
nanoparticles), there remains a pressing need for a versatile platform that can deliver both …
nanoparticles), there remains a pressing need for a versatile platform that can deliver both …
Reversibly crosslinked temperature-responsive nano-sized polymersomes: synthesis and triggered drug release
Water-soluble temperature responsive triblock copolymers, poly (ethylene oxide)-b-poly
(acrylic acid)-b-poly (N-isopropylacrylamide)(PEO-PAA-PNIPAM), were prepared in one pot …
(acrylic acid)-b-poly (N-isopropylacrylamide)(PEO-PAA-PNIPAM), were prepared in one pot …
Polymeric Vesicles: Design, Synthesis and Characterization
Y Yang - 2021 - search.proquest.com
Synthetic nanovesicles, known as liposomes, are assembled from synthetic lipids as
encapsulation devices for delivery of small molecules and are now a key component of …
encapsulation devices for delivery of small molecules and are now a key component of …
Semiconducting polymer nanocavities: Porogenic synthesis, tunable host–guest interactions, and enhanced drug/siRNA delivery
Nanocavities composed of lipids and block polymers have demonstrated great potential in
biomedical applications such as sensors, nanoreactors, and delivery vectors. However, it …
biomedical applications such as sensors, nanoreactors, and delivery vectors. However, it …
Polymersome carriers: from self-assembly to siRNA and protein therapeutics
DA Christian, S Cai, DM Bowen, Y Kim… - European Journal of …, 2009 - Elsevier
Polymersomes are polymer-based vesicular shells that form upon hydration of amphiphilic
block copolymers. These high molecular weight amphiphiles impart physicochemical …
block copolymers. These high molecular weight amphiphiles impart physicochemical …
Stimuli-responsive polymer–prodrug hybrid nanoplatform for multistage siRNA delivery and combination cancer therapy
Nanoparticles (NPs) formulated with cationic lipids and/or polymers have shown substantial
potential for systemic delivery of RNA therapeutics such as small interfering RNA (siRNA) for …
potential for systemic delivery of RNA therapeutics such as small interfering RNA (siRNA) for …
Triblock copolymer-encapsulated nanoparticles with outstanding colloidal stability for siRNA delivery
J Qian, X Gao - ACS applied materials & interfaces, 2013 - ACS Publications
A new generation of siRNA nanocarrier with compact, uniform size and excellent colloidal
stability has been developed by combining inorganic nanoparticles with rationally designed …
stability has been developed by combining inorganic nanoparticles with rationally designed …
Intracellular biomacromolecule delivery by stimuli responsive protein vesicles loaded by hydrophobic ion pairing
MA Gray, A de Janon, M Seeler, WT Heller… - bioRxiv, 2024 - biorxiv.org
Therapeutic biomacromolecules are highly specific, which results in controlled therapeutic
effect and less toxicity than small molecules. However, proteins and nucleic acids are large …
effect and less toxicity than small molecules. However, proteins and nucleic acids are large …
Bioreducible cationic polymer-based nanoparticles for efficient and environmentally triggered cytoplasmic siRNA delivery to primary human brain cancer cells
KL Kozielski, SY Tzeng, BA Hurtado De Mendoza… - ACS …, 2014 - ACS Publications
siRNA nanomedicines can potentially treat many human diseases, but safe and effective
delivery remains a challenge. DNA delivery polymers such as poly (β-amino ester) s …
delivery remains a challenge. DNA delivery polymers such as poly (β-amino ester) s …
Polymersomes spanning from nano-to microscales: advanced vehicles for controlled drug delivery and robust vesicles for virus and cell mimicking
Polymersomes provide a highly promising platform for mimicking biological membranes as
well as for controlled delivery of various pharmaceuticals and biopharmaceuticals. The …
well as for controlled delivery of various pharmaceuticals and biopharmaceuticals. The …